secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunovant, Inc. (IMVT)
CIK:        0001764013
Form:       8-K
Filed at:   2022-01-07T23:59:59+00:00
Accession:  0001764013-22-000007
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunovant to present corporate overview at J.P. Morgan Healthcare Conference on Jan 13, 2022
--------------------------------------------------------------------------------

- CEO Pete Salzmann to present on Thursday, January 13, 2022 at 9:45am ET.
- Webcast available via investor relations section of Immunovant's website.
- No new financial or clinical data announced in the press release.
- Presentation is part of the 40th Annual J.P. Morgan Healthcare Conference (Jan 10-13).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764013/000176401322000007/0001764013-22-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764013/000176401322000007/imvt-20220107.htm
  HTML page:      https://secwatch.observer/filing/0001764013-22-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer